Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siân Jones

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|May 20, 2016
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer TumorsChristopher A Hamm, Diarmuid Moran, Kakuturu Rao, et al.
The Journal of Pathology|November 22, 2011
Low-grade serous carcinomas of the ovary contain very few point mutationsSiân Jones, Tian-Li Wang, Robert J Kurman, et al.
Familial Cancer|September 22, 2014
Familial and sporadic pancreatic cancer share the same molecular pathogenesisAlexis L Norris, Nicholas J Roberts, Siân Jones, et al.
The American Journal of Pathology|April 8, 2009
Frequent activating mutations of PIK3CA in ovarian clear cell carcinomaKuan-Ting Kuo, Tsui-Lien Mao, Siân Jones, et al.
Genome Research|August 19, 2007
A multidimensional analysis of genes mutated in breast and colorectal cancersJimmy Lin, Christine M Gan, Xiaosong Zhang, et al.
Molecular Cancer Therapeutics|December 8, 2010
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancerMaria C Villarroel, N V Rajeshkumar, Ignacio Garrido-Laguna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma RiskMyvizhi Esai Selvan, Marjorie G Zauderer, Charles M Rudin, et al.
Science (New York, N.Y.)|September 10, 2010
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinomaSiân Jones, Tian-Li Wang, Ie-Ming Shih, et al.
Human Mutation|August 25, 2009
The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutationsAnthony R Dallosso, Siân Jones, Duncan Azzopardi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2008
Comparative lesion sequencing provides insights into tumor evolutionSiân Jones, Wei-Dong Chen, Giovanni Parmigiani, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|May 20, 2016
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer TumorsChristopher A Hamm, Diarmuid Moran, Kakuturu Rao, et al.
The Journal of Pathology|November 22, 2011
Low-grade serous carcinomas of the ovary contain very few point mutationsSiân Jones, Tian-Li Wang, Robert J Kurman, et al.
Familial Cancer|September 22, 2014
Familial and sporadic pancreatic cancer share the same molecular pathogenesisAlexis L Norris, Nicholas J Roberts, Siân Jones, et al.
The American Journal of Pathology|April 8, 2009
Frequent activating mutations of PIK3CA in ovarian clear cell carcinomaKuan-Ting Kuo, Tsui-Lien Mao, Siân Jones, et al.
Genome Research|August 19, 2007
A multidimensional analysis of genes mutated in breast and colorectal cancersJimmy Lin, Christine M Gan, Xiaosong Zhang, et al.
Molecular Cancer Therapeutics|December 8, 2010
Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancerMaria C Villarroel, N V Rajeshkumar, Ignacio Garrido-Laguna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma RiskMyvizhi Esai Selvan, Marjorie G Zauderer, Charles M Rudin, et al.
Science (New York, N.Y.)|September 10, 2010
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinomaSiân Jones, Tian-Li Wang, Ie-Ming Shih, et al.
Human Mutation|August 25, 2009
The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutationsAnthony R Dallosso, Siân Jones, Duncan Azzopardi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2008
Comparative lesion sequencing provides insights into tumor evolutionSiân Jones, Wei-Dong Chen, Giovanni Parmigiani, et al.
Pageof 6